Glenview Capital Management - Q3 2020 holdings

$3.19 Billion is the total value of Glenview Capital Management's 45 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 29.5% .

 Value Shares↓ Weighting
THC  TENET HEALTHCARE CORP$484,351,000
+35.3%
19,761,3530.0%15.20%
+54.1%
TAK BuyTAKEDA PHARMACEUTICAL CO LTDsponsored ads$299,508,000
+3.1%
16,788,589
+3.7%
9.40%
+17.4%
BHC SellBAUSCH HEALTH COS INC$232,443,000
-18.8%
14,957,708
-4.4%
7.30%
-7.5%
CI BuyCIGNA CORP NEW$221,932,000
-9.1%
1,310,027
+0.6%
6.97%
+3.4%
HCA SellHCA HEALTHCARE INC$204,290,000
-2.4%
1,638,515
-24.0%
6.41%
+11.1%
MCK BuyMCKESSON CORP$188,733,000
+0.9%
1,267,259
+4.0%
5.92%
+14.9%
DXC SellDXC TECHNOLOGY CO$182,395,000
-7.8%
10,218,215
-14.8%
5.72%
+5.0%
LH SellLABORATORY CORP AMER HLDGS$131,496,000
+7.8%
698,442
-4.9%
4.13%
+22.8%
HOLX SellHOLOGIC INC$96,393,000
-12.6%
1,450,171
-25.1%
3.03%
-0.5%
VIAC SellVIACOMCBS INCcl b$96,349,000
-28.2%
3,439,825
-40.2%
3.02%
-18.3%
MTOR SellMERITOR INC$81,065,000
-24.9%
3,871,291
-29.0%
2.54%
-14.5%
NUAN SellNUANCE COMMUNICATIONS INC$79,864,000
-37.4%
2,406,267
-52.3%
2.51%
-28.7%
ABC SellAMERISOURCEBERGEN CORP$79,443,000
-17.5%
819,674
-14.2%
2.49%
-6.0%
FMC SellF M C CORP$73,555,000
-35.6%
694,509
-39.5%
2.31%
-26.7%
IQV SellIQVIA HLDGS INC$66,045,000
-15.6%
418,985
-24.0%
2.07%
-3.8%
UHS SellUNIVERSAL HLTH SVCS INCcl b$61,604,000
-2.2%
575,634
-15.1%
1.93%
+11.3%
CTVA SellCORTEVA INC$48,135,000
-28.6%
1,670,774
-33.6%
1.51%
-18.8%
MAR SellMARRIOTT INTL INC NEWcl a$40,524,000
-34.5%
437,717
-39.4%
1.27%
-25.4%
BSX SellBOSTON SCIENTIFIC CORP$39,931,000
-46.2%
1,045,052
-50.5%
1.25%
-38.7%
MOH SellMOLINA HEALTHCARE INC$38,141,000
-35.5%
208,374
-37.2%
1.20%
-26.5%
MYGN BuyMYRIAD GENETICS INC$35,964,000
+75.1%
2,757,993
+52.3%
1.13%
+99.5%
CAR SellAVIS BUDGET GROUP$34,778,000
-33.2%
1,321,354
-41.9%
1.09%
-24.0%
HUM SellHUMANA INC$34,390,000
-48.2%
83,089
-51.5%
1.08%
-41.1%
BKD SellBROOKDALE SR LIVING INC$31,970,000
-18.7%
12,586,554
-5.6%
1.00%
-7.6%
EXPE BuyEXPEDIA GROUP INC$31,673,000
+51.1%
345,433
+35.4%
0.99%
+72.0%
ENDP SellENDO INTL PLC$28,758,000
-11.2%
8,714,484
-7.8%
0.90%
+1.1%
ESI SellELEMENT SOLUTIONS INC$26,102,000
-24.7%
2,483,523
-22.2%
0.82%
-14.2%
MIK SellMICHAELS COS INC$21,758,000
-12.1%
2,253,499
-35.6%
0.68%
+0.1%
FISV BuyFISERV INC$19,983,000
+21.7%
193,915
+15.3%
0.63%
+38.4%
LYFT BuyLYFT INC$18,705,000
+45.8%
678,952
+74.7%
0.59%
+65.8%
DGX SellQUEST DIAGNOSTICS INC$18,313,000
-70.6%
159,954
-70.7%
0.58%
-66.5%
DVA SellDAVITA INC$16,574,000
-73.4%
193,506
-75.4%
0.52%
-69.7%
EBAY SellEBAY INC.$15,097,000
-48.1%
289,767
-47.7%
0.47%
-40.8%
URI SellUNITED RENTALS INC$13,864,000
-71.2%
79,450
-75.4%
0.44%
-67.2%
MDT NewMEDTRONIC PLC$11,835,000113,882
+100.0%
0.37%
AMGN NewAMGEN INC$11,514,00045,303
+100.0%
0.36%
MSFT NewMICROSOFT CORP$11,287,00053,664
+100.0%
0.35%
PEAK NewHEALTHPEAK PROPERTIES INC$11,048,000406,928
+100.0%
0.35%
BAX BuyBAXTER INTL INC$10,666,000
+61.4%
132,623
+72.8%
0.34%
+84.1%
PRAH BuyPRA HEALTH SCIENCES INC$9,528,000
+333.7%
93,925
+316.0%
0.30%
+390.2%
WELL NewWELLTOWER INC$6,833,000124,039
+100.0%
0.21%
BHVN SellBIOHAVEN PHARMACTL HLDG CO L$6,309,000
-28.3%
97,047
-19.4%
0.20%
-18.5%
FLDM NewFLUIDIGM CORP DEL$6,014,000809,369
+100.0%
0.19%
GOOGL  ALPHABET INCcap stk cl a$5,635,000
+3.4%
3,8450.0%0.18%
+18.0%
VVI NewVIAD CORP$1,062,00050,995
+100.0%
0.03%
EW ExitEDWARDS LIFESCIENCES CORP$0-3,375
-100.0%
-0.01%
HST ExitHOST HOTELS & RESORTS INC$0-741,628
-100.0%
-0.22%
PACB ExitPACIFIC BIOSCIENCES CALIF IN$0-3,153,150
-100.0%
-0.30%
CAR ExitAVIS BUDGET GROUPcall$0-500,000
-100.0%
-0.32%
TMO ExitTHERMO FISHER SCIENTIFIC INC$0-81,555
-100.0%
-0.82%
UNH ExitUNITEDHEALTH GROUP INC$0-110,866
-100.0%
-0.90%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-16
Signatures

The EDGAR filing(s) were signed by:

About Glenview Capital Management

Glenview Capital Management is a well-known investment management firm that was founded in 2001 by Larry Robbins. The company is headquartered in New York City and manages over $10 billion in assets. Glenview Capital Management is known for its long-term investment strategy and its focus on fundamental analysis. The company invests in a wide range of industries, including healthcare, technology, and consumer goods.

Larry Robbins, the CEO and founder of Glenview Capital Management, is a well-respected figure in the finance industry. He has been recognized for his investment expertise and has been featured in numerous publications, including Forbes and The Wall Street Journal. In addition to Robbins, Glenview Capital Management has a team of experienced professionals, including COO Mark Horowitz and Chief Investment Officer Lee Ainslie.

Glenview Capital Management has a strong track record of delivering solid returns to its investors. The company's investment philosophy is centered around identifying undervalued companies with strong fundamentals and holding them for the long-term. This approach has proven successful, as Glenview Capital Management has consistently outperformed the market over the years.

Overall, Glenview Capital Management is a reputable investment management firm with a strong team of professionals and a proven investment strategy. While past performance is not indicative of future results, investors looking for a long-term investment strategy may want to consider Glenview Capital Management as a potential investment option.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TENET HEALTHCARE CORP42Q3 202316.7%
HCA HOLDINGS INC42Q3 20239.1%
MCKESSON CORP40Q3 20238.2%
FLEXTRONICS INTL LTD38Q2 20234.5%
BROOKDALE SR LIVING INC38Q3 20232.1%
MERITOR INC36Q1 20223.0%
FMC CORP34Q2 20236.4%
UNIVERSAL HLTH SVCS INC34Q3 20235.0%
HUMANA INC31Q4 202112.1%
ENDO INTL PLC30Q1 20222.8%

View Glenview Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Glenview Capital Management Q3 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Butterfly Network, Inc.February 14, 20239,746,8345.5%
Quantum-Si IncFebruary 14, 20234,249,9563.6%
MERITOR, INC.February 22, 20223,544,3335.0%
ATI Physical Therapy, Inc.Sold outFebruary 14, 202200.0%
Evolv Technologies Holdings, Inc.February 14, 2022749,4610.5%
Velocity Acquisition Corp.Sold outFebruary 14, 202200.0%
Bausch Health Companies Inc.December 13, 202117,078,6574.8%
NewHold Investment Corp.June 04, 20211,114,8626.5%
Longview Acquisition Corp. IIApril 02, 20215,000,0007.2%
HighCape Capital Acquisition Corp.March 15, 20211,033,7398.7%

View Glenview Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-01-16
13F-HR2023-11-14
SC 13G2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15

View Glenview Capital Management's complete filings history.

Compare quarters

Export Glenview Capital Management's holdings